If you’ve been prescribed finasteride for enlarged prostate symptoms, you probably left the clinic with a quick "this should help shrink the prostate over a few months" and not much else. That’s normal. But it’s also why so many men end up Googling side effects at 11 p.m., wondering if the symptom they just noticed is the medication talking.
Finasteride works. For men with a genuinely enlarged prostate, it can reduce gland volume by roughly 20 to 30 percent over six to twelve months, easing the weak stream, the constant nighttime trips, the never-quite-empty feeling. The FDA approved finasteride 5 mg (Proscar) specifically for benign prostatic hyperplasia, or BPH, back in 1992, and it has decades of real-world data behind it.
The catch is that finasteride changes hormones. Specifically, it blocks the conversion of testosterone into dihydrotestosterone (DHT), and DHT does a lot of things beyond growing prostate tissue. That’s where the side effects come from. Most are manageable. A few deserve a real conversation with your prescriber.
How Finasteride for Enlarged Prostate Actually Works
Finasteride is a 5-alpha-reductase inhibitor. By lowering DHT levels by about 70 percent, it gradually shrinks the prostate and reduces the mechanical pressure on the urethra. According to the NIH National Library of Medicine, most men start noticing symptom improvement around the three to six month mark, not in the first few weeks.
That slow timeline matters. It means side effects, if they show up, usually appear before the benefits do. Knowing what to watch for helps you decide whether to push through or call your doctor.
1. Sexual Side Effects (The Most Talked About)
This is the category most men ask about, and honestly the most studied. In the original clinical trials, somewhere between 2 and 8 percent of men reported one or more of the following:
- Decreased libido
- Erectile dysfunction
- Reduced ejaculate volume
- Trouble reaching orgasm
For most patients these effects are mild and often improve over the first year of treatment. For a smaller subset they persist, and the post-finasteride syndrome conversation, while still debated in the literature, is real enough that the FDA updated the label in 2012 to reflect reports of sexual dysfunction continuing after stopping the drug.
If you’re already managing ED, this matters even more. Some men do well combining finasteride with a PDE5 inhibitor, and our breakdown of tadalafil daily vs on-demand dosing is worth reading if your doctor has mentioned that route.
2. Mood Changes and Depression
This one gets missed. DHT and related neurosteroids influence brain chemistry, and a meaningful number of men on finasteride report new or worsening low mood, anxiety, or trouble concentrating. A 2017 JAMA Dermatology analysis flagged a small but real association between 5-alpha-reductase inhibitors and depressive symptoms, particularly in older men.
What I’d tell a patient: if you notice persistent low mood, irritability, or loss of interest in things you normally enjoy in the first few months, don’t shrug it off as stress or aging. Mention it. The fix is often as simple as reassessing whether finasteride is the right tool for your BPH, or trying an alternative class like an alpha-blocker.
3. Breast Tenderness and Gynecomastia
Lower DHT means a relatively higher estrogen-to-androgen ratio, and some men respond to that shift with breast tissue changes. The numbers are small, roughly 1 to 2 percent in BPH trials, but it’s not rare enough to ignore.
Watch for:
- Tenderness or soreness in one or both breasts
- A firm lump under the nipple
- Visible swelling
Any new breast lump deserves an exam, full stop. The vast majority are benign gynecomastia, but male breast cancer, while uncommon, has been reported in men taking 5-alpha-reductase inhibitors, and the Mayo Clinic recommends getting any new mass evaluated promptly.
4. PSA Suppression (The Quiet One)
Finasteride lowers your PSA reading by roughly half. That doesn’t mean it’s protecting your prostate, it means your lab number no longer reflects what it would without the drug. If your urologist isn’t doubling your PSA result to interpret it correctly, an early prostate cancer signal could be missed.
Always make sure every doctor ordering a PSA knows you’re on finasteride. This is also why finasteride for enlarged prostate is usually paired with regular digital rectal exams and an informed PSA monitoring plan, not PSA alone.
If you’re weighing finasteride against other options, our comparison of the best treatments for an enlarged prostate lays out the alpha-blockers, combination therapy, and procedural alternatives like UroLift.
5. A Slightly Higher Risk of High-Grade Prostate Cancer
This is the one buried in the label. The PCPT trial found that men on finasteride had a lower overall rate of prostate cancer, but among those who did develop cancer, a slightly higher proportion had high-grade disease. Whether that’s a real biological effect or a detection artifact is still debated, but it’s why the FDA includes the warning.
For most men with significant BPH symptoms, the symptom relief outweighs the risk. But it’s worth a five-minute conversation with your urologist about your personal cancer risk profile before starting.
What to Do If Side Effects Show Up
A few practical points worth knowing:
- Most sexual and mood side effects appear in the first three months. If you’re going to have them, you usually know early.
- Don’t stop finasteride cold without telling your prescriber. Your BPH symptoms will return, often within a few months.
- Some men do better on a lower dose, the 1 mg version used for hair loss, when BPH symptoms are mild. Our finasteride vs minoxidil comparison covers that lower-dose use in detail.
- If cost is the issue, generic finasteride is widely available and you can compare prices on finasteride at edrugstore.com.
The Bottom Line
Finasteride for enlarged prostate symptoms is a well-studied, effective option, and most men tolerate it without major problems. But the five side effects above, sexual changes, mood shifts, breast tissue changes, PSA suppression, and the cancer-grade question, are real enough that you should know them before you start, not after. Ask your prescriber which monitoring schedule makes sense for you, and bring up any change you notice early rather than waiting for your next annual visit.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA Drug Safety Communication on 5-ARIs, label warning on high-grade prostate cancer risk.
- MedlinePlus: Finasteride, patient-facing dosing and side effect overview.
- Mayo Clinic: Finasteride oral route, clinical guidance on side effects and monitoring.
- JAMA Dermatology, analysis linking 5-ARIs and depressive symptoms.
- New England Journal of Medicine, PCPT trial, prostate cancer prevention data underlying the high-grade cancer warning.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More